Testing effectiveness (Phase 2)Looking for participantsNCT06628947
What this trial is testing
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Who this might be right for
Retinitis Pigmentosa
Kiora Pharmaceuticals, Inc. 36